nab-paclitaxel (nab-P) + carboplatin (C) induction therapy in patients (Pts) with squamous (SCC) NSCLC: Interim safety results from the phase 3 ABOUND.sqm studyE. Kim, Jeanna Knoble, Melissa L. Johnson et al.|Annals of Oncology|2016Cited by 0